The canonical Wnt/beta-catenin pathway is crucial in many physiological processes during embryonic development, from cell proliferation to the patterning and differentiation of the complex architecture of many organs, such as the vascular and central nervous systems. For these reasons and to ensure tissue homeostasis from the embryonic stage up to and during adulthood, the action of Wnt ligands needs to be finely regulated at a spatiotemporal level via secreted inhibitors. Here we focus on the Wnt antagonist Wif1 (Wnt inhibitory factor 1), which has been implicated in regulating vasculature development and angiogenesis and is associated with human retinal diseases such as age-related macular degeneration and diabetic retinopathy. Recent findings also support the lack of wif1 as a possible contributing factor to the onset of benign vascular malformations in the brain, such as cerebral cavernous angioma. Using a zebrafish genetic model carrying a wif1 mutation and combining whole-mount immunohistochemistry and reporter gene expression with time-lapse confocal microscopy, we are investigating the requirement of wif1 for the development of the eye and vasculature. In addition, our data provide first insights into compensatory crosstalks between Wnt signalling inhibitors as a mechanism ensuring the robustness of tissue development and homeostasis, with potential implications for understanding pathological conditions in humans. This research highlights the importance of considering mechanisms of gene compensation and transcriptional adaptation when using a mutant line to study the function of a gene of interest, thus considering it as a complementary method to knockdown via microinjection of morpholinos rather than a replacement technique. Particularly interesting is also the possible role that these adaptive and compensatory mechanisms can play in human pathologies, where they could prevent the degeneration of benign conditions and the development of more severe phenotypes.

The Wnt inhibitory factor 1: a case of genetic adaptation? / Sartori, S., Scimone, C., Guglielmi, L., Simonetti, E., Corraini, D., Gilioli, G., Carl, M., D’Angelo, R., Poggi, L.. - ELETTRONICO. - (2024). (4th ITALIAN ZEBRAFISH MEETING (IZM) Palermo 07/02/2024 - 09/02/2024).

The Wnt inhibitory factor 1: a case of genetic adaptation?

Sartori, Samuele;Scimone, Concetta;Guglielmi, Luca;Carl, Matthias;Poggi, Lucia
2024-01-01

Abstract

The canonical Wnt/beta-catenin pathway is crucial in many physiological processes during embryonic development, from cell proliferation to the patterning and differentiation of the complex architecture of many organs, such as the vascular and central nervous systems. For these reasons and to ensure tissue homeostasis from the embryonic stage up to and during adulthood, the action of Wnt ligands needs to be finely regulated at a spatiotemporal level via secreted inhibitors. Here we focus on the Wnt antagonist Wif1 (Wnt inhibitory factor 1), which has been implicated in regulating vasculature development and angiogenesis and is associated with human retinal diseases such as age-related macular degeneration and diabetic retinopathy. Recent findings also support the lack of wif1 as a possible contributing factor to the onset of benign vascular malformations in the brain, such as cerebral cavernous angioma. Using a zebrafish genetic model carrying a wif1 mutation and combining whole-mount immunohistochemistry and reporter gene expression with time-lapse confocal microscopy, we are investigating the requirement of wif1 for the development of the eye and vasculature. In addition, our data provide first insights into compensatory crosstalks between Wnt signalling inhibitors as a mechanism ensuring the robustness of tissue development and homeostasis, with potential implications for understanding pathological conditions in humans. This research highlights the importance of considering mechanisms of gene compensation and transcriptional adaptation when using a mutant line to study the function of a gene of interest, thus considering it as a complementary method to knockdown via microinjection of morpholinos rather than a replacement technique. Particularly interesting is also the possible role that these adaptive and compensatory mechanisms can play in human pathologies, where they could prevent the degeneration of benign conditions and the development of more severe phenotypes.
2024
Selected oral communication (talk) presented by S. Sartori, 7 February 2024. No abstract book published
Palermo
Selected oral communication (talk) presented by S. Sartori, 7 February 2024. No abstract book published
The Wnt inhibitory factor 1: a case of genetic adaptation? / Sartori, S., Scimone, C., Guglielmi, L., Simonetti, E., Corraini, D., Gilioli, G., Carl, M., D’Angelo, R., Poggi, L.. - ELETTRONICO. - (2024). (4th ITALIAN ZEBRAFISH MEETING (IZM) Palermo 07/02/2024 - 09/02/2024).
Sartori, Samuele; Scimone, Concetta; Guglielmi, Luca; Simonetti, Edoardo; Corraini, Daniele; Gilioli, Giorgio; Carl, Matthias; D’Angelo, Rosalia; Pogg...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11572/511375
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex ND
social impact